Transcript Document

PARKINSON’S AND THE EYES
Seeing How
Parkinson’s
Affects The Eyes
Kay Dombkowski, O.D.
DEFINITION
 Parkinson’s Disease is a
progressive degenerative
disorder of the central nervous
system
 Parkinson’s Disease is caused by the
death of dopamine-containing cells
in the substantia nigra region of the
midbrain
 Cause of cell death is unknown
 Result of cell death causes a loss of
ability to execute smooth,
controlled movements
PARKINSON’S AND THE EYES
OPHTHALMOLOGICAL
SYMPTOMS, CAUSES AND TREATMENTS
DIFFICULTY MOVING THE EYES
 Difficulty in beginning a movement of
the eyes or an inability to move the
eyes quickly
 Smooth movement of the eyes is
impaired and movement is slow and
jerky
 Difficulties in moving the eyes are
usually improved by Parkinson’s
medication
PARKINSON’S AND THE EYES
DOUBLE VISION
 Impaired coordination of the muscles
inhibits proper alignment, causing
double vision
 May be worse at near with a
convergence insufficiency
 Bifocals may prevent eyes from
converging, or aiming in, toward a near,
or reading, target.
 Prism glasses may help with symptoms or
two separate pairs of glasses may be
preferable
 Other causes of double vision may be
unrelated to Parkinson’s. If the problem
continues, consult an optometrist so
further testing can be carried out
PARKINSON’S AND THE EYES
BLURRED VISION
 May be caused by:
 Due to difficulty moving and aligning the
eyes
 A side effect of anti-Parkinson’s drugs
 Blurred vision may occur at any time
in the course of medical treatment
 May improve with time
 If blurred vision persists or worsens,
consult your doctor.
 If you already wear reading glasses, a
slight modification to these might
improve blurred vision.
 Your optometrist will be able to advise
you about this.
PARKINSON’S AND THE EYES
DRY EYES
 Most common ocular complaint in
Parkinson’s patients
 People with Parkinson’s often find that
they blink less frequently which may, on
rare occasions, lead to conjunctivitis.
 The treatment is usually antibiotics from the
optometrist.
 Fewer blinks while reading impacts the
tear film and causes decreased vision
 Parkinson’s medications can cause and
worsen dry eye
 Artificial tears can help patient’s comfort
PARKINSON’S AND THE EYES
INVOLUNTARY CLOSURE OF EYE LIDS
 Blepharospasm occurs when the muscle that
closes the eyelid contracts or goes into
spasm and is rare in Parkinson’s patients.
 Result may be repeated twitching of the eyelid,
difficulty in keeping the eyelid open and
sometimes complete closure, interfering with
vision.
 The cause and treatment of blepharospasm
is confusing because the levodopa drugs that
are used to treat Parkinson’s sometimes
cause it, but on other occasions these drugs
can help improve it.
 In mild cases, simply treating ocular surface
disease can help.
 Occasionally, injections of the drug Botox are
used for treatment.
PARKINSON’S AND THE EYES
HALLUCINATIONS
 Hallucinations can manifest early in the
course of Parkinson’s and may directly
result from the disease
 Should be monitored closely, as they
may occur in patients with early disease
who are not yet medicated.
 In those that are medicated, a reduction in
medication may be considered.
 Often seen in patients taking dopamine
agonists and levodopa. Seek advice from your
physician if you are experiencing
hallucinations.
PARKINSON’S AND THE EYES
CONTRAST SENSITIVITY
 A reduction in contrast sensitivity
is a difficulty seeing in low light
levels and an inability to make out
clearly the definition of items such
as a light-colored object on a light
background.
 This may also affect the ease with
which fine print can be read.
 The problem may improve with
the treatment of Parkinson’s with
levodopa
PARKINSON’S AND THE EYES
COLOR VISION
 Parkinson's disease patients
demonstrate significantly higher
error rates on color vision tests
than age-matched controls
 Dopamine reduction in cells of
the retina leads to decreased
color vision and contrast
sensitivity
PARKINSON’S AND THE EYES
VISUAL SPATIAL ORIENTATION
 Difficulty in judging the space
around them
 May not be able to assess
accurately the distance between
objects
 Occupational therapists can
help with advice about
organizing space and carrying
out everyday activities
PARKINSON’S AND THE EYES
GLAUCOMA AND PARKINSON’S
 Glaucoma
 A group of eye conditions that damage the optic
nerve
 Adverse effects of Parkinson’s medications
 May cause narrow angle glaucoma and should be
avoided or used with caution
 Care
 It is helpful if the Parkinson’s specialist and the
optometrist and/or ophthalmologist work
together when prescribing medication for people
who have Parkinson’s and glaucoma.
PARKINSON’S AND THE EYES
LOOKING FORWARD
PERSONAL VISION CARE
 If you have any difficulties with your
eyesight you should consult your physician
to consider adjusting medications to ease
symptoms
 Your optometrist will manage your visual
concerns once medication doses are stable
 Have optometrist collaborate with
occupational therapist
PARKINSON’S AND THE EYES
OTHER FACTORS
 Many problems with vision will
not be related to Parkinson’s at
all and instead will have a
different cause:
 Other co-existing conditions,
such as a cataract
 Age related visual problems,
such as presbyopia
PARKINSON’S AND THE EYES
WHAT CAN I DO?
GET INVOLVED
 The mission of The Parkinson’s
Institute (The PI) is to provide
comprehensive patient care, while
discovering new treatment options to
improve the quality of life for all
Parkinson’s disease (PD) patients. As
America’s only independent nonprofit organization combining
research and patient care for PD
under one roof, we are committed to
changing the landscape of movement
disorder treatment and research.
 cause
 care
 cure
PARKINSON’S AND THE EYES
PARTICIPATE IN ADVANCED RESEARCH
 Participating in Clinical Trials at The Parkinson’s
Institute and Clinical Center means joining a group
of individuals with a common goal of finding new
therapies for symptom control and hopefully one
day a cure.
 The Parkinson's Progression Markers Initiative
(PPMI) is a landmark five-year clinical study aiming
to identify biomarkers of Parkinson's disease
progression. People recently diagnosed with PD
who are not currently taking medications are
needed — and so are individuals who have neither
PD, nor a close relative with PD, to serve as
controls.
 PPMI site at the Parkinson’s Institute and Clinical
Center
PARKINSON’S AND THE EYES
PARTICIPATE IN ADVANCED RESEARCH
 Take an active role in groundbreaking
research by providing your DNA sample
and answering surveys online.
 Join 4,500 other patients in this research
study to understand the causes of
Parkinson's disease and find potential
treatments.
 Goal is 10,000 patients
 https://www.23andme.com/pd/
PARKINSON’S AND THE EYES
SUPPORT
STAY INFORMED AND CONNECTED
 Your generous financial support is an
investment in the Institute’s mission to find
the cause of Parkinson’s disease, provide
world class care for patients, and work
towards a cure
 Take classes to stay informed of latest
updates
 Stay connected to support groups for
emotional well-being
PARKINSON’S AND THE EYES
REFERENCES
 V. Biousse, B.C. Skibell, R.L. Watts, et al, Ophthalmologic Features of Parkinson’s Disease, 62 NEUROLOGY
177-180 (2004).
 Parkinson’s and Eyes, PARKINSON’S DISEASE SOCIETY,
http://www.parkinsons.org.uk/PDF/FS27_Parkinsonsandeyes.pdf (last visited Aug. 28, 2011).
 R. A. Armstrong, Visual Symptoms in Parkinson's Disease, PARKINSON’S DISEASE (MAY 25, 2011),
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109513/?tool=pubmed.
 Neil K. Archibald, Michael P. Clarke, Urs P. Mosimann & David J. Burn, The Retina in Parkinson’s Disease,
132 BRAIN 1128 (2009), available at http://brain.oxfordjournals.org/content/132/5/1128.full.pdf.
 The Michael J. Fox Foundation for Parkinson’s Research, Parkinson’s Progression Markers Initiative, THE
MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH, http://www.michaeljfox.org/living_PPMI.cfm
(last visited Sept. 1, 2011).
 23andMe, 23andMe Parkinson’s Community: Strength in numbers, 23ANDME,
https://www.23andme.com/pd/ (last visited Sept. 1, 2011).
 About the Institute, THE PARKINSON’S INSTITUTE AND CLINICAL CENTER,
http://www.thepi.org/index.php?src= (last visited Nov. 14, 2011).
PARKINSON’S AND THE EYES
Contact me:
[email protected]
THANK YOU